echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > The relationship between aggressive prostate cancer and human genetics

    The relationship between aggressive prostate cancer and human genetics

    • Last Update: 2022-09-07
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    By genetically sequencing prostate cancer tumors from donors in Australia, Brazil and South Africa, the team identified a new classification (classification scheme) and cancer drivers for prostate cancer that not only differentiates patients based on genetic ancestry, but also predicts which ones Cancer can be life-threatening—a task that is currently proving to be challenging


    "Our knowledge of prostate cancer is severely limited to studies in Western populations," said corresponding author Professor Vanessa Hayes


    "Prostate cancer is the silent killer of our region," said Riana Bornman, a professor at the University of Pretoria, an international expert in men's health and clinical lead for the Southern Africa Prostate Cancer Research in South Africa


    Through sophisticated whole-genome sequencing, a method that maps the entire genetic code of cancer cells, more than 2 million cancer-specific genomic variants were discovered in 183 men with untreated prostate tumors in three study regions


    Professor Hayes said: "We found that Africans are affected by more acquired genetic alterations (including cancer drivers), which have important implications for the control and treatment of prostate cancer ancestry


    Computational biologist Dr Weerachai Jaratlerdsiri from the University of Sydney, lead author of the Nature paper, said: "Using cutting-edge computational data science, we can identify patterns including variants in all types of cancer, and we A new classification of prostate cancer was revealed, which was then linked to different disease outcomes


    Dr Tingting Gong, lead author of the paper in Genome Medicine, painstakingly sifted through genomic data for major changes in the structure of chromosomes (molecules that contain genetic information) during her PhD at the University of Sydney


    "We showed dramatic differences in accessing complex genomic variation in tumors from Africa and Europe, which has implications for disease progression and opens up new opportunities for treatment," said Dr.


    This cancer genome resource may be the first and largest in the world to contain African data


    Professor Bornman explained: "By including Africa, we are not only taking the first steps towards globalized precision medicine, but ultimately reducing the impact of prostate cancer mortality in rural Africa


    Prof Hayes added: "The strength of this research is the ability to generate and process all the data through a single technical and analytical pipeline


    The two studies, published in Nature and Genome Medicine, are part of the legacy of the late Archbishop Emeritus Desmond Tutu


    Professor Hayes recalled: “The Archbishop was diagnosed with advanced prostate cancer at the age of 66 and passed away in late December 2021.



    1. Weerachai Jaratlerdsiri, Jue Jiang, Tingting Gong, Sean M.


    2. Tingting Gong, Weerachai Jaratlerdsiri, Jue Jiang, Cali Willet, Tracy Chew, Sean M.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.